Geezer, come on. How can a short "taking profits" pressure a stock down?????????
Who ever is selling doesn't really care about price at this point. Just nuts. Good ol' Fink, provider of endless buying opportunities.
Anyone who doesn't think the hold will be lifted very soon, doesn't know the history of such things with the dysfunctional FDA. GERN's was lifted recently, as was Halo's and many more. International pressure is mounting and Obama see's this as an easy diversion to many more complicated issues he would like to get off the front page. Obama is engaging the FDA; now.
Wonder what long is selling? Didn't they do a deal with Lincoln a long time ago. Could they still have some left over shares they are liquidating.
And even the 8% rate will not be paid in cash. It will also be rolled into the subsequent equity deal next year. So, even though this is a debt deal, which most bio's don't like to do because of money needs, no interest will be paid and capital structure of company does not even change as warrants and equity stay the same for a year.
Yes , no dilution this year with this finance and principle repayment of note next year in equity and warrants. No warrant issued this year. Believe me, lenders are not doing this for the 8%. They are betting on big equity(and warrants) stake they will get next year.
CEO just getting enough money to clear the way for higher equity prices when full results are announced. Then, all note holders are locked into subsequent finance.
Lenders have not been announced yet but will be when first payment to company closes.
Good deal for company if you believe results will be good. If they were not sure of good results they would have tried for much more money now with much worse terns; warrants and low priced stock today.
These knuckleheads just seem to say/write whatever they want and are able to post on yahoo as if undeniable fact. This large put trade was done between bid/ask and was more than likely a fund hedging European exposure by BUYING put. Watch for big selloff in Europe over the next few months.
Also, yesterday 5000 nov 19 calls bought at .09. And today, over 12k of the aug 16 calls done. Most on offer around 30 to 34 cents with one block of 6400 calls at offer of .30.
As I have said, they are pigs at the trough. They give owners(shareholders) nothing but excuses. Ma, Leiberman, and Castle. Wake up.
It used to not be this way with vaso. Salaries and stock bonuses were reasonable in the past. But now, a sense of entitlement has overpowered common sense and fairness. Ma should know better.
I don't see much of a change. Although, this T-shirt looks new. Good work Ma and Leiberman and Castle. Maybe some underwear next.
EECP® Therapy Heal Your Heart T-Shirt
AGN wants to do one, but cant find one to do .Ackman implies going outside would be dangerous for AGN.
Hey, just overpay for RGRX. With all the patents, you could "justify" overpaying(say 200m+) and really #$%$ off valiant and Ackman. Get on the phone Fink.......
Got to be kidding? A old fashioned holding company in this business world? What are those Permian Basin assets worth in this environment? That's the hottest area in energy.
This company screams breakup. How much market cap is hidden here?
Enhanced External Counterpulsation on Delayed Onset Muscle Soreness
This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by David Grant U.S. Air Force Medical Center
David Grant U.S. Air Force Medical Center
First received: May 21, 2014, Completion date: March, 2015
Last updated: June 24, 2014
Last verified: June 2014
This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.